Literature DB >> 18673483

DNA methylation biomarkers to assess therapy and chemoprevention for non-small cell lung cancer.

Steven A Belinsky1, Joan H Schiller, Christine A Stidley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18673483      PMCID： PMC2683838          DOI： 10.1111/j.1753-4887.2008.00061.x

Source DB:  PubMed          Journal:  Nutr Rev        ISSN： 0029-6643            Impact factor:   7.110


× No keyword cloud information.
  8 in total

1.  Gene promoter methylation in plasma and sputum increases with lung cancer risk.

Authors:  Steven A Belinsky; Donna M Klinge; Joseph D Dekker; Mitzi W Smith; Theresa J Bocklage; Frank D Gilliland; Richard E Crowell; Daniel D Karp; Christine A Stidley; Maria A Picchi
Journal:  Clin Cancer Res       Date:  2005-09-15       Impact factor: 12.531

2.  Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort.

Authors:  Steven A Belinsky; Kieu C Liechty; Frederick D Gentry; Holly J Wolf; Justin Rogers; Kieu Vu; Jerry Haney; Tim C Kennedy; Fred R Hirsch; York Miller; Wilbur A Franklin; James G Herman; Stephen B Baylin; Paul A Bunn; Tim Byers
Journal:  Cancer Res       Date:  2006-03-15       Impact factor: 12.701

3.  Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms.

Authors:  Steven D Gore; Stephen Baylin; Elizabeth Sugar; Hetty Carraway; Carole B Miller; Michael Carducci; Michael Grever; Oliver Galm; Tianna Dauses; Judith E Karp; Michelle A Rudek; Ming Zhao; B Douglas Smith; Jasper Manning; Anchalee Jiemjit; George Dover; Abbie Mays; James Zwiebel; Anthony Murgo; Li-Jun Weng; James G Herman
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

4.  DNA methylation changes after 5-aza-2'-deoxycytidine therapy in patients with leukemia.

Authors:  Allen S Yang; Ketan D Doshi; Sang-Woon Choi; Joel B Mason; Rajan K Mannari; Vazganush Gharybian; Rene Luna; Asif Rashid; Lanlan Shen; Marcos R H Estecio; Hagop M Kantarjian; Guillermo Garcia-Manero; Jean-Pierre J Issa
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

5.  Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.

Authors:  L C Clark; G F Combs; B W Turnbull; E H Slate; D K Chalker; J Chow; L S Davis; R A Glover; G F Graham; E G Gross; A Krongrad; J L Lesher; H K Park; B B Sanders; C L Smith; J R Taylor
Journal:  JAMA       Date:  1996-12-25       Impact factor: 56.272

6.  Predicting lung cancer by detecting aberrant promoter methylation in sputum.

Authors:  W A Palmisano; K K Divine; G Saccomanno; F D Gilliland; S B Baylin; J G Herman; S A Belinsky
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

7.  Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis.

Authors:  S A Belinsky; K J Nikula; W A Palmisano; R Michels; G Saccomanno; E Gabrielson; S B Baylin; J G Herman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

8.  Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum.

Authors:  S A Belinsky; M J Grimes; E Casas; C A Stidley; W A Franklin; T J Bocklage; D H Johnson; J H Schiller
Journal:  Br J Cancer       Date:  2007-04-03       Impact factor: 7.640
  8 in total
  2 in total

Review 1.  Biomarkers and the genetics of early neoplastic lesions.

Authors:  Sudhir Srivastava; William E Grizzle
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

2.  Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers.

Authors:  Jun Shen; Ziling Liu; Nevins W Todd; Howard Zhang; Jipei Liao; Lei Yu; Maria A Guarnera; Ruiyun Li; Ling Cai; Min Zhan; Feng Jiang
Journal:  BMC Cancer       Date:  2011-08-24       Impact factor: 4.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.